Skip to main content
Signal8

Graf James A

SEC insider (Form 3/4/5 filer). CIK 0001519672. Chief Financial Officer at NKGen Biotech, Inc. (NKGN). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 6, 2024. Located in SANTA ANA, CA.

Companies Graf James A has filed insider reports for

  • NKGen Biotech, Inc. (NKGN): Officer, Chief Financial Officer
Graf James A profile photo

Graf James A

CIK: 0001519672

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NKGen Biotech, Inc. logo
NKGN

NKGen Biotech, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • NKGen Biotech, Inc. logo
    NKGN

    NKGen Biotech, Inc.

    Dec 6, 2024
    Award

    Stock Option (right to buy)

    Direct
    500K shares-

1-1 of 1